Skip to content

Palvella Therapeutics, Inc.: 10-Q filed 2015-08-13

What Palvella Therapeutics, Inc. reported in its quarterly report filed 2015-08-13 (fiscal Q2 2015): 28 published measures, 73 facts as tagged in accession 0001193125-15-290039.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-13
Fiscal period
fiscal Q2 2015
Accession
0001193125-15-290039 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Palvella Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-3014,477,523USD
At 2014-12-3121,884,168USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-303,330,327USD
At 2014-12-313,877,750USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-3011,147,196USD
At 2014-12-3118,006,418USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-3010,027,305USD
At 2014-12-3118,474,211USD
At 2014-06-301,485,006USD
At 2013-12-313,689,382USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,529,999USD91
2015-01-01 to 2015-06-30-7,234,733USD181
2014-04-04 to 2014-06-30-2,881,637USD88
2014-01-01 to 2014-06-30-3,661,542USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-3074,286USD181
2014-01-01 to 2014-06-304,961USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-30160,244USD91
2015-01-01 to 2015-06-30377,864USD181
2014-04-04 to 2014-06-30698,227USD88
2014-01-01 to 2014-06-302,071,106USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-73,041,781USD
At 2014-12-31-65,807,048USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-18USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-301,811,356USD
At 2014-12-312,052,221USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-06-30485,374USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,534,430USD91
2015-01-01 to 2015-06-30-7,235,763USD181
2014-04-04 to 2014-06-30-2,769,925USD88
2014-01-01 to 2014-06-30-3,441,142USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-3012,641,721USD
At 2014-12-3119,805,425USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-3053USD91
2015-01-01 to 2015-06-304,223USD181
2014-04-04 to 2014-06-30113,793USD88
2014-01-01 to 2014-06-30223,083USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-303,022,477USD
At 2014-12-313,543,762USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,725,592USD91
2015-01-01 to 2015-06-303,250,222USD181
2014-04-04 to 2014-06-301,118,920USD88
2014-01-01 to 2014-06-302,341,666USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3029,429,522shares
At 2014-12-3129,279,522shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3085,503,241USD
At 2014-12-3184,627,283USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2015-06-30-1,343,694USD
At 2014-12-31-843,097USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-06-30307,850USD
At 2014-12-31333,988USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-30635,561USD
At 2014-12-31743,865USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,529,999USD91
2015-01-01 to 2015-06-30-7,234,733USD181
2014-04-04 to 2014-06-30-2,881,637USD88
2014-01-01 to 2014-06-30-3,661,560USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,427,864USD91
2015-01-01 to 2015-06-30-7,735,330USD181
2014-04-04 to 2014-06-30-2,874,983USD88
2014-01-01 to 2014-06-30-3,658,515USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,969,082USD91
2015-01-01 to 2015-06-304,363,405USD181
2014-04-04 to 2014-06-302,349,232USD88
2014-01-01 to 2014-06-303,170,582USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-06-30154,555USD181
2014-01-01 to 2014-06-30189,463USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-04-01 to 2015-06-304,484USD91
2015-01-01 to 2015-06-305,253USD181
2014-04-04 to 2014-06-302,081USD88
2014-01-01 to 2014-06-302,665USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2015-01-01 to 2015-06-301,206USD181
2014-01-01 to 2014-06-3018USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-68,553USD181

Inspect the source

Entity
Palvella Therapeutics, Inc. / CIK 0001583648
Captured
2026-09-20T09:22:58.497Z
SEC response SHA-256
6b68c40c9037b15f9345bb6bb1fdc7777b1252c77cab2e34faa81275beefef40

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001583648.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))